EULAR European Meeting 2015
YHEC presented posters at the Annual European Congress of Rheumatology Congress 2015. Read about some of YHEC’s research presentations below.
Modelling the costs and outcomes associated with sequence of treatment with and without tofacitinib for the treatment of moderate to severe rheumatoid arthritis in the US. L Claxton, M Taylor, D Moynagh, D Gruben, G Wallenstein, A Singh
The economic value of tofacitinib 5 mg BID in the treatment of moderate to severe rheumatoid arthritis: a Canadian analysis. JC Woolcott, G Blackhouse, L Claxton, G Wallenstein, T Tran, R Goeree, M Taylor, D Moynagh, A Singh